Beta defensin 2 - Planton GmbH

Drug Profile

Beta defensin 2 - Planton GmbH

Alternative Names: Antimicrobial peptides - PLANTON; Recombinant-human-beta-defensin-2; rHuB-D2

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Planton
  • Class Antibacterials
  • Mechanism of Action Beta defensin modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Atopic dermatitis; Bacterial infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Atopic-dermatitis in Australia (Topical, Cream)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Bacterial-infections in Australia (Topical, Cream)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top